Estrogen-related receptor alpha (ERRα) promotes the migration, invasion and angiogenesis of breast cancer stem cell-like cells.
- Published in:
- Medical Oncology, 2024, v. 41, n. 3, p. 1, doi. 10.1007/s12032-024-02329-1
- By:
- Publication type:
- Article
Works matching IS 13570560 AND DT 2024 AND VI 41 AND IP 3
Results: 18
1
2
The combined anti-tumor effects of 5-fluorouracil and neurokinin receptor inhibitor, aprepitant, against colorectal cancer: In vitro and in vivo study.
- Published in:
- Medical Oncology, 2024, v. 41, n. 3, p. 1, doi. 10.1007/s12032-024-02312-w
- By:
- Publication type:
- Article
3
TRIM29 modulates proteins involved in PTEN/AKT/mTOR and JAK2/STAT3 signaling pathway and suppresses the progression of hepatocellular carcinoma.
- Published in:
- Medical Oncology, 2024, v. 41, n. 3, p. 1, doi. 10.1007/s12032-024-02307-7
- By:
- Publication type:
- Article
4
Evaluation of TRIM63 RNA in situ hybridization (RNA-ISH) as a potential biomarker for alveolar soft-part sarcoma (ASPS).
- Published in:
- Medical Oncology, 2024, v. 41, n. 3, p. 1, doi. 10.1007/s12032-024-02305-9
- By:
- Publication type:
- Article
5
Correction to: Exploring the advances of single‑cell RNA sequencing in thyroid cancer: a narrative review.
- Published in:
- 2024
- By:
- Publication type:
- Correction Notice
6
Venetoclax with decitabine or azacitidine in relapsed or refractory acute myeloid leukemia.
- Published in:
- Medical Oncology, 2024, v. 41, n. 3, p. 1, doi. 10.1007/s12032-024-02302-y
- By:
- Publication type:
- Article
7
CRP inhibits the osteoblastic differentiation of OPCs via the up-regulation of primary cilia and repression of the Hedgehog signaling pathway.
- Published in:
- Medical Oncology, 2024, v. 41, n. 3, p. 1, doi. 10.1007/s12032-024-02301-z
- By:
- Publication type:
- Article
8
Selective targeting or reprogramming of intra-tumoral Tregs.
- Published in:
- Medical Oncology, 2024, v. 41, n. 3, p. 1, doi. 10.1007/s12032-024-02300-0
- By:
- Publication type:
- Article
9
Clinical significance of blocking novel immune checkpoint B7-H4 in urothelial carcinoma of bladder as a potential therapeutic target.
- Published in:
- Medical Oncology, 2024, v. 41, n. 3, p. 1, doi. 10.1007/s12032-024-02299-4
- By:
- Publication type:
- Article
10
Advancements in biosensors for cancer detection: revolutionizing diagnostics.
- Published in:
- Medical Oncology, 2024, v. 41, n. 3, p. 1, doi. 10.1007/s12032-023-02297-y
- By:
- Publication type:
- Article
11
C-5401331 identified as a novel T-cell immunoglobulin and mucin domain-containing protein 3 (Tim-3) inhibitor to control acute myeloid leukemia (AML) cell proliferation.
- Published in:
- Medical Oncology, 2024, v. 41, n. 3, p. 1, doi. 10.1007/s12032-023-02296-z
- By:
- Publication type:
- Article
12
Insights into lenvatinib resistance: mechanisms, potential biomarkers, and strategies to enhance sensitivity.
- Published in:
- Medical Oncology, 2024, v. 41, n. 3, p. 1, doi. 10.1007/s12032-023-02295-0
- By:
- Publication type:
- Article
13
Pyroptosis in cancer treatment and prevention: the role of natural products and their bioactive compounds.
- Published in:
- Medical Oncology, 2024, v. 41, n. 3, p. 1, doi. 10.1007/s12032-023-02293-2
- By:
- Publication type:
- Article
14
Synergistic inhibitory actions of resveratrol, epigallocatechin-3-gallate, and diallyl trisulfide against skin cancer cell line A431 through mitochondrial caspase dependent pathway: a combinational drug approach.
- Published in:
- Medical Oncology, 2024, v. 41, n. 3, p. 1, doi. 10.1007/s12032-023-02292-3
- By:
- Publication type:
- Article
15
Regulation of the P53 tumor suppressor gene and the Mcl-2 oncogene expression by an active herbal component delivered through a smart thermo-pH-sensitive PLGA carrier to improve Osteosarcoma treatment.
- Published in:
- Medical Oncology, 2024, v. 41, n. 3, p. 1, doi. 10.1007/s12032-023-02291-4
- By:
- Publication type:
- Article
16
Unlocking the 'ova'-coming power: immunotherapy's role in shaping the future of ovarian cancer treatment.
- Published in:
- Medical Oncology, 2024, v. 41, n. 3, p. 1, doi. 10.1007/s12032-023-02281-6
- By:
- Publication type:
- Article
17
Up and away with cervical cancer: IL-29 is a promising cytokine for immunotherapy of cervical cancer due to its powerful upregulation of p18, p27, and TRAILR1.
- Published in:
- Medical Oncology, 2024, v. 41, n. 3, p. 1, doi. 10.1007/s12032-023-02276-3
- By:
- Publication type:
- Article
18
A therapeutical insight into the correlation between circRNAs and signaling pathways involved in cancer pathogenesis.
- Published in:
- Medical Oncology, 2024, v. 41, n. 3, p. 1, doi. 10.1007/s12032-023-02275-4
- By:
- Publication type:
- Article